Abstract: An attachment for a wearable collar of an animal may be provided. The attachment may include an electronic device comprising a processor configured to receive or transmit information relating to the animal. An attachment body may be configured to be detachably coupled to the collar worn by the animal. The attachment body may include a cavity housing the electronic device and an opening of the cavity. The opening may provide access to the electronic device housed in the cavity or retaining the electronic device within the cavity via an enclosure element. Each of a plurality of legs may have a connection element. The connection element may be configured to engage with another connection element to detachably couple the attachment body to the collar worn by the animal.

Abstract: A wearable animal information apparatus may be provided that includes a collar configured to be worn around a portion of an animal. The collar may include an inner surface that faces the portion of the animal during use and an outer surface that faces away from the portion of the animal during use. The animal information apparatus may include a base coupled to the collar and a housing configured to couple to the base via an attachment element. The housing may include a plurality of indicators providing visual information relating to at least one of a condition of the animal or an environment surrounding the animal. An electronic device, located within the housing, may include a processor configured to receive or transmit information relating to the animal. The base may include a cavity for receiving the housing and coupling the base to the housing via the attachment element.

Abstract: A monitoring device may be provided that couples to a wearable collar for an animal. A housing may include a cavity with an open top end and a cover movable between a first position wherein the cover closes the open top end of the cavity and a second position wherein the open top end of the cavity is exposed. An electronic device may be positioned within the cavity, the electronic device including a processor configured to receive or transmit information relating to the animal wearing the wearable collar. A first connection portion may be coupled to the housing and configured to attach to a first member of a first terminating end of the wearable collar. A second connection portion may be coupled to the housing and configured to attach to a second member of a second terminating end of the wearable collar.

Abstract: The invention provides (1) methods for modulating gene expression in senescent mammals by administering antioxidant-comprising compositions to the mammals and (2) antioxidant-comprising compositions that modulate gene expression and/or reduce the oxidative stress of such mammals.

Abstract: Described herein are pet food compositions comprising: an insoluble fiber source comprising a lignin; a polyphenol source; and a soluble fiber source; wherein the weight ratio of insoluble fiber to soluble fiber is greater than about 2:1. Methods of making and using these compositions are also described.

Abstract: Described herein are pet food compositions comprising: a beta glucan; and a pentacyclic triterpene; wherein the weight ratio of the beta glucan to the pentacyclic triterpene, is about 1:1. Methods of making and using these compositions are also described.

Abstract: Compositions and methods of treating anxiety or stress in an animal are disclosed. Compositions and methods of reducing or preventing elevated levels of 4-EPS are disclosed. Compositions and methods for promoting growth of beneficial microbes in an animal's microbiome and inhibiting growth of non-beneficial microbes are disclosed. The methods comprise administering to the animal an effective amount of n-3 fatty acids, antioxidants, insoluble fiber and soluble fiber in an effective ratio of insoluble fiber and soluble fiber. Compositions comprise effective amounts of n-3 fatty acids, antioxidants, insoluble fiber and soluble fiber in an effective ratio of insoluble fiber and soluble fiber.

Abstract: Compositions and methods are disclosed for treating anxiety or stress in an animal, for reducing elevated levels of 4-EPS in an animal with elevated 4-EPS levels, for preventing elevated levels of 4-EPS in an animal and for promoting growth of beneficial microbes in an animal's microbiome and inhibiting growth of non-beneficial microbes. The methods comprise administering to the animal an effective amount of soy protein and vitamin C. Compositions are disclosed which comprise amounts of soy protein and vitamin C effective for use in the methods.

Abstract: Methods of analyzing a biological sample obtained from the feline subject for the presence of one or two copies of minor allele A of SNP A1_212891692 and/or to the concentration of beta-amino isobutyrate and/or 2-oxoarginine concentrations in the sample are disclosed. The methods are used in methods to identify a feline subject that has an increased likelihood or risk of calcium oxalate stone formation and in methods of treating a feline subject to reduce risk of calcium oxalate stone formation. The treatment on comprises administering to the feline subject a low arginine diet. Low arginine feline food compositions are disclosed.

Abstract: Disclosed herein is a pet food composition and methods of making a pet food composition using an extrusion process, wherein the resultant pet food composition comprises an enhanced level of resistant starch. The pet food compositions disclosed herein may increase the proportions of beneficial gastrointestinal bacteria, such as Lactobacillus and Bifidobacterium, while decreasing deleterious bacteria such as Megamonas. The improved microbial environment resulting from the pet food compositions disclosed herein having an enhanced level of resistant starch may lead to both improved gastrointestinal and psychobiotic health for the animal consuming the pet food composition.

Abstract: Methods of analyzing a biological sample obtained from the canine subject for the presence of one or two copies one or two copies of minor allele T of SNP Affx-206229307; or one or two copies of minor allele A of SNP Affx-206560187; or one or two copies of minor allele T of SNP Affx-206229307 and one or two copies of minor allele A of SNP Affx-206560187 are disclosed. The methods are used in methods to identify a canine subject that has an increased likelihood or risk of hypothyroidism and in methods of treating a canine subject to reduce risk of hypothyroidism or to treat a canine subject that has hypothyroidism. The treatments comprise administering to the canine subject a low arginine diet and/or comprising an effective amount of a composition comprising a protein source, a carbohydrate source, a vegetable source, and a fruit source. Canine food compositions are disclosed.

Abstract: Methods of identifying canine subjects having an increased likelihood of developing elevated levels of 4-ethylphenyl sulfate, canine stress, canine anxiety and/or an inhibition of growth of beneficial microbes and promotion of growth of harmful microbes are disclosed. Methods comprise analyzing a biological sample obtained from the canine subject for the presence of two copies of a minor allele of the single nucleotide polymorphism BICF2P1175095 in a canine subject. Methods of treating the identified canine subjects by administering an effective amount of tomato pomace are also disclosed. Methods of treating canine subjects for elevated 4-EPS levels, canine anxiety or canine stress are disclosed. Canine food compositions that comprises tomato pomace are disclosed.

Abstract: The present disclosure is directed to an animal food product for promoting dental efficacy including a hydrolyzed protein including one or more amino groups, and a high amylopectin content starch including one or more reducing sugars; wherein the one or more amino groups in the hydrolyzed protein are covalently bonded to the one or more reducing sugars in the high amylopectin content starch. Methods of preparing the animal food product and using the animal food product to promote dental efficacy, such as teeth-cleaning efficacy in an animal are also provided.

Abstract: Disclosed herein are pet food compositions for treating or preventing inflammation or an inflammatory disorder in an animal comprising an effective amount of at least one medium chain triglyceride and an effective amount of at least one omega-3 fatty acid, wherein the at least one medium chain triglycride and the at least one omega-3 fatty acid are present in an amount effect to a provide a synergistic decrease in the amount of circulating cytokines in the companion animal. Also disclosed herein are methods for treating or preventing inflammation or an inflammatory disorder in a companion animal, comprising administering the pet food compositions disclosed herein to the companion animal in need thereof.

Abstract: The present invention encompasses methods and kits employing pattern recognition receptor expression as a measure of systemic health in a subject afflicted with an oral health condition. In particular, the present invention is directed to methods involving measurement of the expression levels of one or more Pattern Recognition Receptors including but not limited to Toll-Like Receptors, myeloid differentiation primary response gene 88 (MyD88), and Nucleotide Binding oligomerization domain containing protein 1 (NOD1), in a companion animal, e.g., a dog or a cat, afflicted with an oral health condition. The described methods enable evaluation of the systemic health of the animal afflicted with an oral health condition by measuring expression levels of the indicated genes as compared to suitable controls.

Abstract: The present invention encompasses pet food compositions that include one or more probiotic microorganisms, which are useful to improve the health of companion animals. For example, the invention encompasses pet food compositions including a probiotic, for example, Lactobacillus, Bifidobacterium and Streptococcus (Enterococcus). The present invention also encompasses the preparation of pet food compositions including one or more probiotic microorganisms intended for methods of maintaining or improving pet health through feeding a pet a pet food composition including the probiotic microorganism.

Abstract: A food composition for managing non-food allergies in companion animals is disclosed, along with a method of managing non-food allergies.

Abstract: The present disclosure may be directed to a system, method, and/or device for providing a pet product to a pet parent. Information relating to the pet product may be displayed. A request for a purchase of a pet product may be received from the pet parent. Title of the requested pet product may be transferred from the supplier to the veterinarian. The transfer of the title from the supplier to the veterinarian may be based on receiving the request for the purchase of the pet product from the pet parent. The requested pet product may be shipped to the pet parent. Title of the pet product may be transferred from the veterinarian to the pet parent. The title of the pet product may be transferred from the veterinarian to the pet parent based on an event. Payout information relating to the requested pet product may be provided.

Abstract: The present invention encompasses methods and kits employing pattern recognition receptor expression as a measure of systemic health in a subject afflicted with an oral health condition. In particular, the present invention is directed to methods involving measurement of the expression levels of one or more Pattern Recognition Receptors including but not limited to Toll Like Receptors, myeloid differentiation primary response gene 88 (MyD88), and Nucleotide Binding oligomerization domain containing protein 1 (NOD1), in a companion animal, e.g., a dog or a cat, afflicted with an oral health condition. The described methods enable evaluation of the systemic health of the animal afflicted with an oral health condition by measuring expression levels of the indicated genes as compared to suitable controls.

Abstract: The present invention encompasses pet food compositions that include one or more probiotic microorganisms, which are useful to improve the health of companion animals. For example, the invention encompasses pet food compositions including a probiotic, for example, Lactobacillus, Bifidobacterium and Streptococcus (Enterococcus). The present invention also encompasses the preparation of pet food compositions including one or more probiotic microorganisms intended for methods of maintaining or improving pet health through feeding a pet a pet food composition including the probiotic microorganism.